Company page

Biolinerx Ltd.

Biolinerx Ltd. (Ticker: BLRX) is a public company based in Israel, with a market capitalization of approximately $14.2 million. The company focuses on developing innovative therapies for cancer and autoimmune diseases. Biolinerx is committed to advancing its pipeline of drug candidates to address unmet medical needs.

profileBLRX:TASEAI content: aiUpdated June 24, 2026/company/bioline-rx-ltd/c-2x1sfslf
Biolinerx Ltd. logo
Ticker
BLRX:TASE
Asset type
Stock
Market cap
$14.2M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
TASE
Currency
ILA